Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence
Introduction and objective: To capture the experience of haemophilia A patients with their devices for coagulation factor reconstitution, the barriers for treatment adherence; and to determine their preferences, presenting a new double-chamber syringe (DCS). Method: A cross-sectional research through a supervised survey and a DCS testing session. Results: Seventy-four (74) patients participated, 50% of them on prophylaxis treatment, and 7 years (median) with their usual treatment (IQR 17.25). In the survey, the DCS received the highest score (75/100, p < 0.001) and it was the most likely to be used in prophylactic treatment (p < 0.001). In the practical testing session (n = 29), 62.1% preferred the DCS, and required 43 seconds as median time (24.5-82) for preparation, vs. 4 minutes (1-15) with their usual treatment (p < 0.001). The favourable opinion of their doctor regarding prophylaxis was very influential on the attitude of participants towards treatment adherence (OR = 1.324, CI 95% = 1.040-1.685, p = 0.023). Conclusions: The DCS was the preferred device, and was likely to encourage prophylaxis.
Main Authors: | , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Grupo Aula Médica
2016
|
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432016000600011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1130-63432016000600011 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1130-634320160006000112017-03-06Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherenceFernández-Arias,IsabelKyung Kim,Hae Haemophilia A Factor VIII Prophylaxis Drug Delivery Systems Medication Adherence Introduction and objective: To capture the experience of haemophilia A patients with their devices for coagulation factor reconstitution, the barriers for treatment adherence; and to determine their preferences, presenting a new double-chamber syringe (DCS). Method: A cross-sectional research through a supervised survey and a DCS testing session. Results: Seventy-four (74) patients participated, 50% of them on prophylaxis treatment, and 7 years (median) with their usual treatment (IQR 17.25). In the survey, the DCS received the highest score (75/100, p < 0.001) and it was the most likely to be used in prophylactic treatment (p < 0.001). In the practical testing session (n = 29), 62.1% preferred the DCS, and required 43 seconds as median time (24.5-82) for preparation, vs. 4 minutes (1-15) with their usual treatment (p < 0.001). The favourable opinion of their doctor regarding prophylaxis was very influential on the attitude of participants towards treatment adherence (OR = 1.324, CI 95% = 1.040-1.685, p = 0.023). Conclusions: The DCS was the preferred device, and was likely to encourage prophylaxis.Grupo Aula MédicaFarmacia Hospitalaria v.40 n.6 20162016-12-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432016000600011en |
institution |
SCIELO |
collection |
OJS |
country |
España |
countrycode |
ES |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-es |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Fernández-Arias,Isabel Kyung Kim,Hae |
spellingShingle |
Fernández-Arias,Isabel Kyung Kim,Hae Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence |
author_facet |
Fernández-Arias,Isabel Kyung Kim,Hae |
author_sort |
Fernández-Arias,Isabel |
title |
Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence |
title_short |
Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence |
title_full |
Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence |
title_fullStr |
Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence |
title_full_unstemmed |
Factor VIII delivery devices in haemophilia A: Barriers and drivers for treatment adherence |
title_sort |
factor viii delivery devices in haemophilia a: barriers and drivers for treatment adherence |
description |
Introduction and objective: To capture the experience of haemophilia A patients with their devices for coagulation factor reconstitution, the barriers for treatment adherence; and to determine their preferences, presenting a new double-chamber syringe (DCS). Method: A cross-sectional research through a supervised survey and a DCS testing session. Results: Seventy-four (74) patients participated, 50% of them on prophylaxis treatment, and 7 years (median) with their usual treatment (IQR 17.25). In the survey, the DCS received the highest score (75/100, p < 0.001) and it was the most likely to be used in prophylactic treatment (p < 0.001). In the practical testing session (n = 29), 62.1% preferred the DCS, and required 43 seconds as median time (24.5-82) for preparation, vs. 4 minutes (1-15) with their usual treatment (p < 0.001). The favourable opinion of their doctor regarding prophylaxis was very influential on the attitude of participants towards treatment adherence (OR = 1.324, CI 95% = 1.040-1.685, p = 0.023). Conclusions: The DCS was the preferred device, and was likely to encourage prophylaxis. |
publisher |
Grupo Aula Médica |
publishDate |
2016 |
url |
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432016000600011 |
work_keys_str_mv |
AT fernandezariasisabel factorviiideliverydevicesinhaemophiliaabarriersanddriversfortreatmentadherence AT kyungkimhae factorviiideliverydevicesinhaemophiliaabarriersanddriversfortreatmentadherence |
_version_ |
1755939078509953024 |